News
Clinical Trial Cleared for GPH101: The First Potentially Curative Sickle Cell Disease Therapy
Januar 22, 2021
Clinical Trial Cleared for GPH101: The First Potentially Curative Sickle Cell Disease Therapy
The U.S. Food & Drug Administration (FDA) has cleared an investigational new drug (IND) application for the experimental gene editing therapy GPH101 by Graphite Bio to initiate a Phase 1/2…
Blood Supply Challenges & Transfusion Care of Patients With Haemoglobinopathies During COVID-19 Pandemic
Januar 22, 2021
Blood Supply Challenges & Transfusion Care of Patients With Haemoglobinopathies During COVID-19 Pandemic
The COVID-19 pandemic has had an impact on blood supply in several countries, jeopardizing the already demanding and often suboptimal care for haemoglobinopathies patients, mainly in developing and low-income countries…
EdiGene Announces Approval in China of its IND Application for CRISPR/Cas 9 Gene Editing Therapy ET-01 in β-thalassaemia
Januar 21, 2021
EdiGene Announces Approval in China of its IND Application for CRISPR/Cas 9 Gene Editing Therapy ET-01 in β-thalassaemia
The Center for Drug Evaluation (CDE) of China‘s National Medical Products Administration (NMPA) has recently approved EdiGene’s application for ET-01, an investigational CRISPR-Cas9 gene editing therapy for patients with transfusion dependent β-thalassaemia. This marks the first…
Just Updated: TIF’s Vaccinations & Therapeutic Drugs for COVID-19 Guide
Januar 7, 2021
Just Updated: TIF’s Vaccinations & Therapeutic Drugs for COVID-19 Guide
Everything you need to know about the different COVID-19 vaccines, both already available and developing, in one place! Discover our newly updated Guide “Vaccinations & Therapeutic Drugs for COVID-19“, containing…
Iranian Blood Transfusion Organization Newsletter – December 2020
Januar 4, 2021
Iranian Blood Transfusion Organization Newsletter – December 2020
The Iranian Blood Transfusion Organization (IBTO) and its most recent activities are featured on TIF’S website.
Blood Under The Microscope Of The European Commission: An Article by TIF’s Executive Director
Dezember 30, 2020
Blood Under The Microscope Of The European Commission: An Article by TIF’s Executive Director
by Dr Androulla Eleftheriou The European Commission published in October 2019 the Evaluation Report of the European legal framework for quality standards and blood, tissues and cells. This framework is…
THALIA App: The Skilled Digital Assistant of People with Thalassaemia and Sickle Cell Disease
Dezember 22, 2020
THALIA App: The Skilled Digital Assistant of People with Thalassaemia and Sickle Cell Disease
Committed to continuing efforts to develop useful tools for individuals with thalassaemia and haemoglobin disorders worldwide, TIF introduces a novel mobile health application for patients with thalassaemia and sickle cell…
COVID-19 Vaccines and Haemoglobin Disorders: The Latest Position Statement of the Thalassaemia International Federation
Dezember 22, 2020
COVID-19 Vaccines and Haemoglobin Disorders: The Latest Position Statement of the Thalassaemia International Federation
In view of the plans made by national health authorities in every country across the world for the widespread vaccination of individuals against the SARS-CoV-2 virus, the Thalassaemia International Federation…
TIF & UNITED Onlus Co-Organizzano il 1° Meeting Associazioni Italiane Sulle Terapie Nuove e Innovative Per le Emoglobinopatie
Dezember 4, 2020
TIF & UNITED Onlus Co-Organizzano il 1° Meeting Associazioni Italiane Sulle Terapie Nuove e Innovative Per le Emoglobinopatie
Alla luce dei rapidi sviluppi scientifici nel campo della talassemia e dell’anemia falciforme con nuovi farmaci e trattamenti che promettono di rivoluzionare la gestione di queste malattie, la Federazione Internazionale…